One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 9,000 employees in locations spanning the globe and 2006 revenues of $3.2 billion. Genzyme has been selected by FORTUNE as one of the "100 Best Companies to Work for" in the United States.
With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopedics, cancer, transplant, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.
Important Safety Information
SYNVISC is used to relieve knee pain due to osteoarthritis (OA). It is for patients who do not get enough relief from simple painkillers such as acetaminophen, or from exercise and physical therapy.
SYNVISC is generally well tolerated. However, it may not work for
everyone. The side effects most commonly seen when SYNVISC is injected into
the knee were pain, swelling and/or fluid buildup around the knee. Cases
where the swelling is extensive or painful should be discussed with your
doctor. Other side effects such as rash have been reported rarely. Before
trying SYNVISC, tell your doctor if you are allergic to products from birds
- such as feathers, eggs or poultry - or if your leg is swollen or
infected. Talk to your doctor before resuming strenuous weight-bearing
|SOURCE Genzyme Corporation|
Copyright©2008 PR Newswire.
All rights reserved